Brightsurf Science News and Current Science News Events
 
Email a Friend Send to a friend
Printer Friendly Print Researchers develop method to rapidly ID optimal drug cocktails

Researchers develop method to rapidly ID optimal drug cocktails

March 18, 2008

New scheme holds promise for treating cancer, other diseases

UCLA researchers have developed a feedback control scheme that can search for the most effective drug combinations to treat a variety of conditions, including cancers and infections. The discovery could play a significant role in facilitating new clinical drug-cocktail trials.




The best known use of drug cocktails has been in the fight against HIV, the virus that causes AIDS. Drug cocktails also have been used to combat several types of cancer. Often, drugs that might not be effective in combating diseases individually do much better in combination.

With the use of the new closed-loop feedback control scheme, an approach guided by a stochastic search algorithm, researchers at the UCLA Henry Samueli School of Engineering and Applied Science and UCLA's Jonsson Comprehensive Cancer Center have devised an invaluable means of identifying potent drug combinations fast and efficiently. Their findings appear in the March 17 online version of the journal Proceedings of the National Academy of Sciences.

It has long been a difficult challenge for clinical researchers to determine the optimal dose of individual drugs used in combination. For example, a researcher testing 10 different concentrations of six drugs in every possible arrangement would be faced with 1 million potential combinations.

"With the development of this optimization method, we've overcome a major roadblock," said study author Chih-Ming Ho, UCLA's Ben Rich-Lockheed Martin Professor and a member of the National Academy of Engineering. "There have always been too many choices and too many combinations to sort through. It was like finding a needle in a haystack."

In one test case, the research team examined how to best prevent a viral infection of host cells. Using the closed-loop optimization scheme, they were able to identify, out of 100,000 possible combinations, the drug cocktails that completely inhibited viral infection after only about a dozen trials. In addition, they found that total inhibition of the virus occurred at much lower drug doses than would be necessary if the drugs were used alone; in fact, the concentrations of the drugs were only about 10 percent of that required when used individually.

"Viruses grow very rapidly and change rapidly as well. Because of that, a virus can become resistant to a particular drug," said Genhong Cheng, a member of the research team at the UCLA Center for Cell Control and UCLA's Jonsson Comprehensive Cancer Center. "This is why it's so important to be able to use a combination of more than one drug. If the virus mutates to become resistant to one drug, it is still sensitive to the other drugs."

Drug combinations can also be used effectively to inhibit infectious diseases because resistance to a single drug is very common, according to Ren Sun, UCLA professor of molecular and medical pharmacology and a member of the research team.

"If we can apply multiple drugs against one infectious agent, it probably will prevent the occurrence of drug resistance," said Sun, who is also a researcher at the Jonsson Cancer Center. "But, of course, when you use multiple drugs, side effects will be strong. With this model, there is a way to optimize the combination to reduce the side effects while maintaining efficacy that will be very beneficial."

"What the search scheme does is it tries to detect trends for optimal output," said Pak Wong, a former UCLA graduate student who participated in the study and is now an assistant professor of mechanical engineering at the University of Arizona. "Basically, the algorithm sees a trend and a direction and drives the trend in that direction. It's like mountain climbing and finding a way to get to the peak. So you keep going, and soon you rapidly find the peak while being guided by a smart search scheme."

In an example used to illustrate the prevention of viral infection of host cells, researchers started with arbitrarily chosen dosages of the drugs. The percentage of non-infected cells under this initial drug-cocktail treatment was fed into the stochastic search algorithm, which essentially helps guide a random search process. The algorithm then suggested the next drug concentrations for producing a higher percentage of non-infected cells. This closed-loop feedback control scheme is carried out continuously until the best combination is found. Randomness is built into the search decision, preventing the trap at local optimum levels and allowing the search process to continue until the optimal drug cocktail is identified.

The model also provides an alternative approach to studying cellular functions. Molecular biologists can identify all the players of a particular regulatory pathway in order to decipher how to block or augment that pathway. Cells are complex systems with many redundant functions, and it is difficult to predict how a cell will respond to multiple stimulations at one time. The model overlooks these details and lets the system determine what works best for itself. If researchers are more interested in how the cellular network functions, this approach can provide an initial bird's-eye view, but it also allows them to home in on the important molecular activities controlled by the best drug combinations.

This search scheme is an extremely effective and versatile tool that can be applied to combat numerous diseases, including cancer, the researchers say, and its multidimensional properties will likely make it useful in a wide variety of additional situations.

The next steps are animal and clinical testing.

University of California - Los Angeles



Related Drug Combination News Articles Drug Combination News and Current Drug Combination Events RSS Drug Combination News and Current Drug Combination Events RSS
VCU Massey Cancer Center Spearheads Novel Clinical Study for Lymphoma Patients
The Virginia Commonwealth University Massey Cancer Center recently opened a National Cancer Institute (NCI)-sponsored, phase II clinical study for certain sub-types of non-Hodgkin's lymphoma.

'Multi-target' immune therapy improves outcomes of severe lupus nephritis
A new treatment using a combination of drugs targeting different parts of the immune system improves the recovery rate for patients with severe lupus involving the kidneys, according to a report in the October Journal of the American Society of Nephrology (JASN).

New Cancer Treatment Targets Both Tumor Cells and Blood Vessels
It takes more than one punch to fight tumors. Often, tumors have more than one way of surviving, and attacking the tumor alone is not enough.

Unique drug combination may hold the key to reversing Type I diabetes
Promising results from a study that tested a new approach for reversing Type 1 diabetes are being presented this week at the American Diabetes Association's 68th Annual Scientific Session in San Francisco.

International health experts to enlist the public in war on African malaria
Philanthropy just got easier and a lot more accessible to the public thanks to the social networking power of the Internet and a ground-breaking partnership between a young British entrepreneur, a global health think tank and an African medical research institute.

New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients
Adding capecitabine, a drug that inhibits DNA synthesis and slows the growth of tumour tissue, to docetaxel, in patients with early breast cancer, leads to more toxicities and does not improve the efficacy of treatment.

Fugitive cancer cells can be blocked by stopping blood cells that aid them
Cancer cells get a helping hand from platelets, specialized blood cells involved in clotting. Platelets shelter and feed tumor cells that stray into the bloodstream, making it easier for cancer to spread, or metastasize.

Older antibiotic gains new respect as potent treatment for tuberculosis
It has no current market, not even a prescription price. Its makers stopped commercial production years ago, because demand was so low.

Ireland Cancer Center researchers advance stem cell gene therapy
Ireland Cancer Center of University Hospitals Case Medical Center researchers have recently made great strides in stem cell gene therapy research by transferring a new gene to cancer patients, via their own stem cells, with the ultimate goal of being able to use stronger chemotherapy treatment with less severe side effects.

HIV drug resistance risk in mothers reduced by combination of common drugs
New research from the University of Alabama at Birmingham (UAB) shows that adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs, potentially improving future treatment options.
More Drug Combination News Articles


Dui Yao: The Art of Combining Chinese Medicinals

Based on 2,000 years of recorded clinical experience, certain combinations of Chinese medicinals work better than others. Although theoretically there may be several possible combinations which might achieve a certain therapeutic effect, in actual fact, one combination in particular gets definite dependable results. This book describes over 100 of the best known, most useful two medicinal...



The People's Guide To Deadly Drug Interactions: How To Protect Yourself From Life-Threatening Drug-Drug, Drug-Food, Drug-Vitamin Combinations (The People's Pharmacy Guides)
by Joe Graedon, Teresa Graedon

Who would've thought grapefruit juice, licorice, and cheddar cheese could be so dangerous? Well, they are, when combined with certain medications. This book continues the People's Pharmacy franchise with an eye-opening guide to the unexpected, dangerous, and sometimes deadly ways foods, vitamins, minerals, herbs, and alcohol can interact with prescription and over-the-counter drugs, and how those...



Combination Products: Regulatory Challenges and Successful Product Development
by Smita Gopalaswamy, Venky Gopalaswamy

The field of combination product development (products born of the integration of medical devices, biologics, and drugs) is so new that, while literature abounds on each part individually, there are very few publications, including FDA documents, available concerning the unique challenges posed by this nascent but fast-growing area. Providing the first in-depth look at this breakthrough field,...



Combination Drug Therapy in Hypertension: Pocketbook (Martin Dunitz Medical Pocket Books)
by Michael Schachter

When hypertension is particularly refractive, a combination of various anti-hypertensive agents has been shown to be particularly effective in lowering the blood pressure to a safe level. Non-hypertension specialists often want to know which drug combination is preferred. Some combinations are safe while others are not recommended. The author guides the reader through this complex maze of...



1,001 Prescription Drugs : Side Effects, Dangerous Combinations and Natural Healing Alternatives for Seniors

In the insiders guide to prescription drugs, you'll get complete coverage of the most commonly prescribed medicines. Clear explanations describe what each drug is supposed to do for you, side effects you may experience, special warnings, information for pregnant and nursing mothers, and helpful hints on how to take your medicine for maximum effectiveness. Plus, you'll find out how to save money...



Development and Approval of Combination Products: A Regulatory Perspective

A step-by-step, integrated approach for successful, FDA-approved combination drug products Using a proven integrated approach to combination drug development, this book guides you step by step through all the preclinical, clinical, and manufacturing stages. Written from an FDA regulatory perspective, the book not only enables you to bring a successful combination drug product to market, it...

Drug combination shows efficacy in psychotic depression.(Adult Psychiatry): An article from: Clinical Psychiatry News
by Sherry Boschert

This digital document is an article from Clinical Psychiatry News, published by Thomson Gale on July 1, 2005. The length of the article is 522 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Drug...



Lexi-Comp Drug Information Handbook for Oncology: A Complete Guide to Combination Chemotherapy Regimens (Lexi-Comp's Drug Reference Handbooks)
by Dominic A., Jr. Solimando

Ideal for Oncology professionals, Lexi-Comp's Drug Information Handbook forOncology offers an all-in-one reference for Oncology-related drug information and combination chemotherapy...



Targeted Cancer Therapy (Current Clinical Oncology) (Current Clinical Oncology)

Emerging technologies in target identification, drug discovery, molecular markers, and imaging are rapidly changing the face of cancer. Targeted Cancer Therapy provides a foundation of knowledge in targeted cancer therapeutics. The treatment of cancer is increasingly being individualized, based on an understanding of underlying biologic mechanisms. Poised to change the landscape in oncology,...



Antiepileptic Drugs: Combination Therapy and Interactions

This book reviews the use of antiepileptic drugs focusing on the interactions between these drugs and between antiepileptics and other drugs. These interactions can be beneficial or can cause harm. The aim of this book is to increase awareness of the possible impact of combination pharmacotherapies. Pharmacokinetic and pharmacodynamic interactions are discussed supported by clinical and...

© 2008 BrightSurf.com